Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis.

Philip B AndreasenOmid RezahosseiniDina L MøllerNeval E WarehamMagda T ThomsenRanya HoumamiAndreas D KnudsenJenny KnudsenJørgen A L KurtzhalsAndreas A RostvedChristian R PedersenAllan RasmussenSusanne D Nielsen

Published in: Immunity, inflammation and disease (2021)

PCP was not detected in liver transplant recipients while on prophylaxis. Though, it worth mentioning that two out of the seven PCP patients received high-dose prednisolone before the PCP event. All liver transplant recipients with PCP were hospitalized, but none died. Randomized clinical trials to determine the optimal duration of prophylaxis are warranted.

Keyphrases

high dose
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
low dose
peritoneal dialysis
prognostic factors
clinical trial
intensive care unit
mechanical ventilation